Array-based identification of common DNA methylation alterations in ulcerative colitis

International Journal of Oncology

Volumn 40, Issue 4, 2012, Pages 983-994

  Koizumi, K E I ^a   Alonso, Sergio ^b   Miyaki, Yuichiro ^a   Okada, Shinichiro ^c   Ogura, Hiroyuki ^a   Shiiya, Norihiko ^a   Konishi, Fumio ^c   Taya, Toshiki ^d   Perucho, Manuel ^b,e,f   Suzuki, Koichi ^c  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Institute of Predictive and Personalized Medicine of Cancer (IMPPC)   (Spain)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d YOKOGAWA ANALYTICAL SYSTEMS INC   (Japan)

^e BURNHAM INSTITUTE   (United States)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Field cancerization; Methylation profiling; Methylation sensitive amplified fragment length polymorphism; Microarray; MS AFLP; Ulcerative colitis associated carcinogenesis

Indexed keywords

GENOMIC DNA;

ADULT; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CANCER CELL CULTURE; CANCER RISK; CANCER SUSCEPTIBILITY; COLON CANCER; COLON CARCINOGENESIS; CPG ISLAND; DNA FINGERPRINTING; DNA METHYLATION; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION SENSITIVE AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; PRIORITY JOURNAL; PROMOTER REGION; ULCERATIVE COLITIS;

ADULT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; CELL LINE, TUMOR; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; DNA METHYLATION; EPIGENOMICS; FEMALE; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84863356403     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1283     Document Type: Article

References (56)

1. Lashner BA, Silverstein MD and Hanauer SB: Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci 34: 1536-1541, 1989. (Pubitemid 19255344)
2. Ekbom A, Helmick C, Zack M and Adami HO: Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323: 1228-1233, 1990. (Pubitemid 20366527)
3. Eaden JA, Abrams KR and Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526-535, 2001. (Pubitemid 32234798)
4. Itzkowitz SH and Present DH: Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11: 314-321, 2005. (Pubitemid 40439686)
5. Pohl C, Hombach A and Kruis W: Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 47: 57-70, 2000. (Pubitemid 30085390)
6. Geboes K: Ulcerative colitis and malignancy. Acta Gastroenterol Belg 63: 279-283, 2000.
7. Provenzale D and Onken J: Surveillance issues in inflammatory bowel disease: ulcerative colitis. J Clin Gastroenterol 32: 99-105, 2001. (Pubitemid 32113237)
8. Itzkowitz SH and Yio X: Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287: G7-G17, 2004. (Pubitemid 38802113)
9. Garrity-Park MM, Loftus EV Jr, Sandborn WJ, Bryant SC and Smyrk TC: Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer. Am J Gastroenterol 105: 1610-1619, 2010.
10. Issa JP: CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 249: 101-118, 2000.
11. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M and Ushijima T: High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989-995, 2006. (Pubitemid 43259882)
12. Nakajima T, Maekita T, Oda I, Gotoda T, Yamamoto S, Umemura S, Ichinose M, Sugimura T, Ushijima T and Saito D: Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Biomarkers Prev 15: 2317-2321, 2006. (Pubitemid 44877064)
13. Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R and Hirohashi S: Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis: a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 32: 970-979, 2000.
14. Ushijima T: Epigenetic field for cancerization. J Biochem Mol Biol 40: 142-150, 2007.
15. INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 58: 3942-3945, 1998.
16. Sato F, Harpaz N, Shibata D, Xu Y, Yin J, Mori Y, Zou TT, Wang S, Desai K, Leytin A, Selaru FM, Abraham JM and Meltzer SJ: Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res 62: 1148-1151, 2002. (Pubitemid 34160301)
17. Issa JP, Ahuja N, Toyota M, Bronner MP and Brentnall TA: Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61: 3573-3577, 2001. (Pubitemid 32694963)
18. Fujii S, Tominaga K, Kitajima K, Takeda J, Kusaka T, Fujita M, Ichikawa K, Tomita S, Ohkura Y, Ono Y, Imura J, Chiba T and Fujimori T: Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in long-standing and extensive ulcerative colitis. Gut 54: 1287-1292, 2005. (Pubitemid 41192492)
19. Gloria L, Cravo M, Pinto A, De Sousa LS, Chaves P, Leitao CN, Quina M, Mira FC and Soares J: DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer 78: 2300-2306, 1996. (Pubitemid 26392827)
20. Yamamoto F, Yamamoto M, Soto JL, Kojima E, Wang EN, Perucho M, Sekiya T and Yamanaka H: Notl-Msell methylation-sensitive amplied fragment length polymorhism for DNA methylation analysis of human cancers. Electrophoresis 22: 1946-1956, 2001. (Pubitemid 32621922)
21. Samuelsson JK, Alonso S, Yamamoto F and Perucho M: DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer. Mutat Res 693: 61-76, 2010.
22. Yamashita K, Dai T, Dai Y, Yamamoto F and Perucho M: Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 4: 121-131, 2003. (Pubitemid 37040828)
23. Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, Yamashita K and Perucho M: Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9: 199-207, 2006. (Pubitemid 43357946)
24. Kageyama S, Shinmura K, Yamamoto H, Goto M, Suzuki K, Tanioka F, Tsuneyoshi T and Sugimura H: Fluorescence-labeled methylation-sensitive amplified fragment length polymorphism (FL-MS-AFLP) analysis for quantitative determination of DNA methylation and demethylation status. Jpn J Clin Oncol 38: 317-322, 2008. (Pubitemid 351583997)
25. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, Ji H, Potash JB, Sabunciyan S and Feinberg AP: The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41: 178-186, 2009.
26. Ehrlich M: DNA methylation in cancer: too much, but also too little. Oncogene 21: 5400-5413, 2002.
27. Yamamoto F and Yamamoto M: A DNA microarray-based methylation-sensitive (MS)-AFLP hybridization method for genetic and epigenetic analyses. Mol Genet Genomics 271: 678-686, 2004. (Pubitemid 39062507)
28. Rouillard JM, Zuker M and Gulari E: OligoArray 2.0: design of oligonucleotide probes for DNA microarrays using a thermodynamic approach. Nucleic Acids Res 31: 3057-3062, 2003. (Pubitemid 37441764)
29. Team RDC: R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, 2009.
30. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL and Paul CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89: 1827-1831, 1992.
31. Holm S: A simple sequentially rejective multiple test procedure. Scand J Statist 6: 65-70, 1979.
32. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V and Quackenbush J: TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378, 2003. (Pubitemid 36184095)
33. Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2009.
34. Huang da W, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC and Lempicki RA: DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 35: W169-W175, 2007.
35. Hosack DA, Dennis G Jr, Sherman BT, Lane HC and Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70, 2003.
36. Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561, 1993. (Pubitemid 23186645)
37. Kanehisa M and Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30, 2000. (Pubitemid 30047706)
38. Kawakami K, Matsunoki A, Kaneko M, Saito K, Watanabe G and Minamoto T: Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer. Cancer Sci 102: 166-174, 2011.
39. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686, 1999. (Pubitemid 29354851)
40. Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, Costello JF, Lang JC, Eng C, Li B, Wright FA, Caligiuri MA and Plass C: Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 10: 1413-1419, 2001. (Pubitemid 32640670)
41. Perucho M, Tokino T and Nakamura Y: Cancer genomics and molecular diagnosis - The Nineteenth International Symposium of Sapporo Cancer Seminar. Jpn J Cancer Res 90: 1273-1276, 1999.
42. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J and Sukumar S: Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405: 974-978, 2000. (Pubitemid 30435057)
43. Shiraishi M, Sekiguchi A, Oates AJ, Terry MJ and Miyamoto Y: HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas. Oncogene 21: 3659-3662, 2002. (Pubitemid 34587698)
44. Shah N and Sukumar S: The Hox genes and their roles in oncogenesis. Nat Rev Cancer 10: 361-371, 2010.
45. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, van Eynde A, Bernard D, Vanderwinden JM, Bollen M, Esteller M, Di Croce L, De Launoit Y and Fuks F: The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874, 2006. (Pubitemid 43255707)
46. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE, Bergman Y, Simon I and Cedar H: Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39: 232-236, 2007. (Pubitemid 46184355)
47. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I and Laird PW: Epigenetic stem cell signature in cancer. Nat Genet 39: 157-158, 2007. (Pubitemid 46184343)
48. Rodriguez J, Vives L, Jorda M, Morales C, Munoz M, Vendrell E and Peinado MA: Genome-wide tracking of unmethylated DNA Alu repeats in normal and cancer cells. Nucleic Acids Res 36: 770-784, 2008. (Pubitemid 351267234)
49. Mazumdar T, De Vecchio J, Shi T, Jones J, Agyeman A and Houghton JA: Hedgehog signaling drives cellular survival in human colon carcinoma cells. Cancer Res 71: 1092-1102, 2011.
50. Hanigan CL, Van Engeland M, De Bruine AP, Wouters KA, Weijenberg MP, Eshleman JR and Herman JG: An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1. Gastroenterology 135: 1652-1664, 2008.
51. Slattery ML, Lundgreen A, Herrick JS, Caan BJ, Potter JD and Wolff RK: Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-beta-signaling pathway. Carcinogenesis 32: 318-326, 2011.
52. Koinuma K, Yamashita Y, Liu W, Hatanaka H, Kurashina K, Wada T, Takada S, Kaneda R, Choi YL, Fujiwara SI, Miyakura Y, Nagai H and Mano H: Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene 25: 139-146, 2006. (Pubitemid 43050012)
53. Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, Halling KC, Cunningham JM, Boardman LA, Qian C, Christensen E, Schmidt SS, Roche PC, Smith DI and Thibodeau SN: Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 26: 146-147, 2000.
54. Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, Rickman BH, Rogers AB, Moroski-Erkul CA, McFaline JL, Schauer DB, Dedon PC, Fox JG and Samson LD: DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 118: 2516-2525, 2008. (Pubitemid 351949779)
55. Killian A, Sarafan-Vasseur N, Sesboue R, Le Pessot F, Blanchard F, Lamy A, Laurent M, Flaman JM and Frebourg T: Contribution of the BOP1 gene, located on 8q24, to colorectal tumorigenesis. Genes Chromosomes Cancer 45: 874-881, 2006. (Pubitemid 44182446)
56. Matts SG: The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 30: 393-407, 1961.